Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

2 S&P 500 ETFs for Growth and Leverage in a Hot Market

With the great returns of the S&P 500 in recent months, investors looking for something more from the index have two trending ETFs to consider.

Garmin’s Growth Signals Wearables Surge: Stocks to Watch

Garmin’s Growth Signals Wearables Surge: Stocks to Watch

Consumer technology companies are outperforming in 2025 as demand for wearables increases. Market-leading Garmin's stock price hits new highs.

3 Precious Metals ETFs Gaining Big as Gold Nears New Highs

3 Precious Metals ETFs Gaining Big as Gold Nears New Highs

Precious metals have surged, with gold seeing all-time highs this year; these three ETFs can help to provide easy exposure to the rally.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

These 3 Defensive Retail Stocks Are Outpacing the Market

Recent economic data shows investors that a potential rotation out of cyclical names is starting, one that could benefit these defensive stocks.

Ray Dalio's Bridgewater Loaded Up on These Stocks in Q4 2024

Bridgewater Associates, the investment management company founded by Ray Dalio 50 years ago, just invested millions in these three stocks.

Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive

Walmart got the market's attention with weaker-than-expected guidance, and warning tariffs would impact the business, but this price dip isn't a signal to sell.

Tesla: 2 Reasons to Buy, 1 Reason to Run

With bullish analysts calling for 45% upside, momentum is clearly starting to swing away from the bears and back to the bulls.

inkl

Read news from The Economist, FT, and more,
with one subscription

Should You Hold NVIDIA Stock for the Long Haul or Trade It?

Should You Hold NVIDIA Stock for the Long Haul or Trade It?

Nvidia stock might be the best opportunity for both investors and traders alike. This mix is as uncommon as the upside in the name.

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks

Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks

Check out these three mega-cap names, valued over $200 billion each, that just authorized a combined $28 billion in buybacks.

3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?

3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?

Beauty stocks are off to an ugly start in 2025, but there may be 1 stock that will lead the rebound as they already beat and raised earnings guidance.

2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul

2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul

As retail sales data comes out for investors to digest and analyze, it becomes clear that the theme favors one stock in the automotive sector.

Fastenal : Growth Trends, Challenges & Key Investment Insights

Fastenal : Growth Trends, Challenges & Key Investment Insights

Fasteners, bolts, screws and studs may seem like a boring business, but its big business for Fastenal which may see sales surge in the "Golden Age" of manufact

Biogen Stock Is Mutating Into a Value Play

Biogen Stock Is Mutating Into a Value Play

Biogen shares have fallen over 70% from its highs nearly 12-years ago, but value investors should take a look at its metrics of just 12.4 P/E and P/B of 1.2X

Get all your
news in one place.

100’s of premium titles.
One news app.

SoundHound AI Stock at a Crossroads—Is a Bottom in Sight?

SoundHound's stock retreat is setting up the market for a solid rebound that will likely begin soon. The Q4 results will show accelerating growth and strength.

Hershey’s Sweet Comeback: Why Investors Are Taking Notice

Hershey's is the iconic chocolate maker that also sells salty and sweet snacks and other candy brands including Twizzlers, Dot's Pretzels, Jolly Rancher, Payday

Occidental Petroleum Will Move Higher in 2025 Say Analysts

Occidental Petroleum builds shareholder equity while paying down debt and a substantial dividend. Worth nearly 2% in mid-February, this distribution will grow.

After Earnings, Is Transocean Stock the Best Energy Play?

Transocean stock just reported its latest quarterly earnings figures, which point to more bullish developments in the company, such as backlog and demand.

Get all your
news in one place.

100’s of premium titles.
One news app.

Nebius Group: NVIDIA’s Investment Sparks All-Time Highs

Shares of Nebius Group (NASDAQ: NBIS) hit record-highs on Friday following a disclosure revealing that NVIDIA purchased almost 1.2 million shares.

SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?

With momentum returning and the uptrend resuming, this looks like a textbook buy-the-dip setup for investors who believe the growth story is still intact.

Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?

Is the rally in Intel shares just beginning after Trump-influenced acquisition talks led to shares rising north of 25% in one week?

Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?

Solid Biosciences just saw a 32% move to the upside after its trial results impressed. What's next for this firm that analysts still see massive potential in?

Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?

With AppLovin shares up close to 1000% in the past year, see how is the company looking toward the future to support its massive valuation.

Alphabet’s Pullback Just Opened a Window for Smart Investors

While the earnings report contained a revenue miss that spooked the market, it's worth remembering that it was still Alphabet's highest ever revenue print.

Moderna: A Generational Opportunity for Investors in 2025

Moderna had a weak quarter but reaffirmed guidance, expecting three new product approvals in 2025 and as many as ten more within three years.

1 … 36 37 38 39

People

113,098 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Intel Corporation

Berkshire Hathaway

the Trump Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

268,528 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play